Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Flat index levels can mask underlying shifts among components; still, broader market movements may occur through price changes in parts.
28,641 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
The canadian prime minister mark warns that U.S. export controls on Anthropic’s latest AI models show the dangers of ...
A bipartisan push in Congress seeks a federal registry for trusted AI agents and a fiduciary standard for robo-adviso...
XRP is testing a long-running support line that has preceded every major rally since 2014, now coinciding with new ET...
A seasoned Wall Street investor reveals a sizable bet on Avalanche, arguing the platform’s treasury mechanics and sca...
A viral Truth Social post from Trump sparked a swift move in crypto markets, with Bitcoin and Ethereum rallying as oi...
The S&P 500 has slipped this year, yet three tech-focused ETFs powering AI names have kept a higher trajectory over t...
A new data snapshot shows a large share of seniors still carry nonmortgage debt as they enter Social Security years. ...
A high-stakes clash between two top AI firms and the Pentagon exemplifies growing concerns about governance, safety, ...
A confidential settlement in Maryland ends a high-profile dispute over HeLa cell patents and profits, signaling a new...
Top tech leaders warn that giving AI labs access to sensitive business data may erode competitive advantages. The iss...
Mosaic's Q3 2025 results spotlight a sharply growing Brazil business, with Brazil EBITDA up 190% year over year. Yet ...